Table 3 Contribution of office blood pressure, risk factor status, evidence of target organ damage or associated clinical conditions to categorization as high-risk patients
Parameter | High-risk patients | Sustained hypertension | White coat hypertension |
|---|---|---|---|
n | 152 (71.7%) | 122 (74.8%) | 30 (61.2%) |
Office blood pressure stage 3 only | 6 (2.8%) | 4 (2.5%) | 2 (4.1%) |
⩾3 Risk factors only | 24 (11.3%) | 18 (11.0%) | 6 (12.2%) |
Target organ damage only | 56 (26.4%) | 44 (27.0%) | 12 (24.5%) |
Associated clinical conditions only | 4 (1.9%) | 2 (1.2%) | 2 (4.1%) |
Office blood pressure stage 3 or ⩾3 risk factors | 32 (15.1%) | 24 (14.7%) | 8 (16.3%) |
Office blood pressure stage 3 or ⩾3 risk factors or target organ damage | 126 (59.4%) | 100 (61.3%) | 26 (53.1%) |
Office blood pressure stage 3 and ⩾3 risk factors and target organ damage and associated clinical conditions | 3 (1.4%) | 3 (1.8%) | 0 (0.0%) |
